404 related articles for article (PubMed ID: 18941129)
41. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
[TBL] [Abstract][Full Text] [Related]
42. Effect of methimazole on warfarin anticoagulation in a case of Graves' disease.
Akin F; Yaylali GF; Bastemir M; Yapar B
Blood Coagul Fibrinolysis; 2008 Jan; 19(1):89-91. PubMed ID: 18180622
[TBL] [Abstract][Full Text] [Related]
43. Thyrotoxicosis.
Kannan CR; Seshadri KG
Dis Mon; 1997 Sep; 43(9):601-77. PubMed ID: 9301645
[TBL] [Abstract][Full Text] [Related]
44. The effects of long-term antithyroid drug treatment on serum reverse T3 in patients with Graves' disease.
Dahlberg PA; Karlsson FA; Wide L
Acta Med Scand; 1980; 207(5):375-8. PubMed ID: 6155758
[TBL] [Abstract][Full Text] [Related]
45. Short-term single daily dose treatment of hyperthyroid Graves' disease.
Bakker-Tervoort MA; Lütjens A; Monasch E
Neth J Med; 1985; 28(10):454-6. PubMed ID: 3841191
[No Abstract] [Full Text] [Related]
46. [Observation on therapeutic effect of picking therapy on Graves' disease].
Li GL; Zhou ZX; Li JM
Zhongguo Zhen Jiu; 2006 Nov; 26(11):769-71. PubMed ID: 17165495
[TBL] [Abstract][Full Text] [Related]
47. Acute ataxia, Graves' disease, and stiff person syndrome.
Chia SY; Chua R; Lo YL; Wong MC; Chan LL; Tan EK
Mov Disord; 2007 Oct; 22(13):1969-71. PubMed ID: 17712846
[TBL] [Abstract][Full Text] [Related]
48. [Current issues in the treatment of thyrotoxicosis].
Papi G
Recenti Prog Med; 2005 Nov; 96(11):560-5. PubMed ID: 16499167
[TBL] [Abstract][Full Text] [Related]
49. Class IV lupus nephritis associated with Graves' disease.
Fu LS; Yang LY; Chen WP; Chao T; Ooi SK; Lin CY
Child Nephrol Urol; 1992; 12(1):51-4. PubMed ID: 1606584
[TBL] [Abstract][Full Text] [Related]
50. Controversies in the pharmacological treatment of Graves' disease in children.
De Luca F; Valenzise M
Expert Rev Clin Pharmacol; 2018 Nov; 11(11):1113-1121. PubMed ID: 30417713
[TBL] [Abstract][Full Text] [Related]
51. Reversible pulmonary hypertension in neonatal Graves disease.
O'Donovan D; McMahon C; Costigan C; Oslizlok P; Duff D
Ir Med J; 1997; 90(4):147-8. PubMed ID: 9267095
[TBL] [Abstract][Full Text] [Related]
52. Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.
Suzuki S; Takei M; Nishio S; Inaba H; Sato A; Yamazaki M; Shinomiya K; Hashizume K
Horm Metab Res; 2009 Jul; 41(7):548-53. PubMed ID: 19280551
[TBL] [Abstract][Full Text] [Related]
53. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis.
Vogel A; Elberling TV; Hørding M; Dock J; Rasmussen AK; Feldt-Rasmussen U; Perrild H; Waldemar G
Psychoneuroendocrinology; 2007 Jan; 32(1):36-43. PubMed ID: 17097812
[TBL] [Abstract][Full Text] [Related]
54. [Thyrotoxic neuromyopathies].
Sidibe EH; Diagne PM; Ly AB; Ndiaye IP; Sow AM
Rev Neurol (Paris); 1998 May; 154(4):330-3. PubMed ID: 9773061
[TBL] [Abstract][Full Text] [Related]
55. [Erythrocyte carbonic anhydrase I and zinc concentrations in thyrotoxicosis reflect integrated thyroid hormone levels over the previous few months].
Yoshida K
Rinsho Byori; 2007 Jun; 55(6):560-5. PubMed ID: 17657991
[TBL] [Abstract][Full Text] [Related]
56. The use of the E-rosette as a test for remission in Graves' disease treated with antithyroid drugs.
Farid NR; Munro R; Row VV; Volpé R
Clin Endocrinol (Oxf); 1974 Jan; 3(1):55-61. PubMed ID: 4407296
[No Abstract] [Full Text] [Related]
57. Hickam's dictum: Myasthenia Gravis presenting concurrently with Graves' disease.
Sehgal S; Rebello R; Wolmarans L; Elston M
BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28882932
[TBL] [Abstract][Full Text] [Related]
58. The safety and efficacy of antithyroid drugs.
Azizi F
Expert Opin Drug Saf; 2006 Jan; 5(1):107-16. PubMed ID: 16370960
[TBL] [Abstract][Full Text] [Related]
59. [Case of Graves' disease presenting only with rapid consciousness disturbance].
Nagaishi A; Yukitake M; Kuroda Y
Rinsho Shinkeigaku; 2006 Apr; 46(4):285-7. PubMed ID: 16768098
[TBL] [Abstract][Full Text] [Related]
60. Behavioral assessment of children and adolescents with Graves' disease: A prospective study.
Hamed SA; Attiah FA; Abdulhamid SK; Fawzy M
PLoS One; 2021; 16(4):e0248937. PubMed ID: 33914772
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
